ARTICLE | Company News
Helsinn, Dr. Reddy’s Laboratories Ltd. deal
October 26, 2015 7:00 AM UTC
Helsinn and Dr. Reddy’s settled patent litigation for Aloxi palonosetron in the U.S. Dr. Reddy’s will now be able to market a generic version of Aloxi in the U.S. on Sept. 20, 2018, or earlier under ...